Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition

Cellular and Molecular Life Sciences

Volumn 70, Issue 23, 2013, Pages 4463-4477

  Aparicio, Luis A ^b   Abella, Vanessa ^a   Valladares, Manuel ^b   Figueroa, Angélica ^a  

^a SERGAS   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Epithelial to mesenchymal transition; Posttranscriptional regulation; RNA binding proteins; Tumor progression

Indexed keywords

ALTERNATIVE SPLICING FACTOR PROTEIN; EPITHELIAL SPLICING REGULATORY PROTEIN; GROWTH FACTOR; HUMAN ANTIGEN R; MESSENGER RNA PRECURSOR; PROTEIN SAM68; REGULATOR PROTEIN; RNA BINDING PROTEIN; SPLICING FACTOR 2 PROTEIN; TRISTETRAPROLIN; UNCLASSIFIED DRUG; ZEPPO1 PROTEIN;

ALTERNATIVE RNA SPLICING; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE LOCATION; HUMAN; MOLECULAR DYNAMICS; POLYADENYLATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVIEW; RNA CAPPING; RNA METABOLISM; RNA TRANSLATION; RNA TRANSPORT; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MODELS, GENETIC; NEOPLASMS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84889879702     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1379-0     Document Type: Review

References (136)

1. Adams CL, Nelson WJ (1998) Cytomechanics of cadherin-mediated cell-cell adhesion. Curr Opin Cell Biol 10(5):572-577
2. Perez-Moreno M, Jamora C, Fuchs E (2003) Sticky business: orchestrating cellular signals at adherens junctions. Cell 112(4):535-548
3. Yonemura S (2011) Cadherin-actin interactions at adherens junctions. Curr Opin Cell Biol 23(5):515-522. doi: 10.1016/j.ceb.2011.07.001
4. McCrea PD, Turck CW, Gumbiner B (1991) A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 254(5036):1359-1361
5. Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z (1994) Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol 14(12):8333-8342
6. Christofori G (2006) New signals from the invasive front. Nature 441(7092):444-450. doi: 10.1038/nature04872
7. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14(6):818-829. doi: 10.1016/j.devcel.2008.05.009
8. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890. doi: 10.1016/j.cell.2009.11.007
9. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392(6672):190-193
10. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420-1428. doi: 10.1172/JCI39104
11. Bierie B, Moses HL (2006) TGF-beta and cancer. Cytokine Growth Factor Rev 17(1-2):29-40. doi: 10.1016/j.cytogfr.2005.09.006
12. Massagué J (2008) TGFbeta in cancer. Cell 134(2):215-230. doi: 10.1016/j.cell.2008.07.001
13. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848-851
14. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, García De Herreros A (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2(2):84-89. doi: 10.1038/35000034
15. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2(2):76-83. doi: 10.1038/35000025
16. Yang J, Mani S, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7):927-939
17. Dupre-Crochet S, Figueroa A, Hogan C, Ferber EC, Bialucha CU, Adams J, Richardson EC, Fujita Y (2007) Casein kinase 1 is a novel negative regulator of E-cadherin-based cell-cell contacts. Mol Cell Biol 27(10):3804-3816
18. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N (1996) Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 271(23):13811-13815
19. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy H, Behrens J, Sommer T, Birchmeier W (2002) Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 4(3):222-231
20. Figueroa A, Kotani H, Toda Y, Mazan-Mamczarz K, Mueller E, Otto A, Disch L, Norman M, Ramdasi R, Keshtgar M, Gorospe M, Fujita Y (2009) Novel roles of hakai in cell proliferation and oncogenesis. Mol Biol Cell 20(15):3533-3542. doi: 10.1091/mbc.E08-08-0845
21. Figueroa A, Fujita Y, Gorospe M (2009) Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF. Cell Cycle 8(22):3648-3651
22. Rodríguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, Blanco M, Aparicio G, Fernández-Puente P, Blanco FJ, Lorenzo MJ, Aparicio LA, Figueroa A (2011) A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues. Proteomics. doi: 10.1002/pmic.201000809
23. Rodríguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, Aparicio LA, Figueroa A (2011) Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer 11:474. doi: 10.1186/1471-2407-11-474
24. Abella V, Valladares M, Rodriguez T, Haz M, Blanco M, Tarrío N, Iglesias P, Aparicio LA, Figueroa A (2012) miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression. PLoS One 7(12):e52568. doi: 10.1371/journal.pone.0052568
25. Aparicio LA, Valladares M, Blanco M, Alonso G, Figueroa A (2012) Biological influence of Hakai in cancer: a 10-year review. Cancer Metastasis Rev. doi: 10.1007/s10555-012-9348-x
26. Tenenbaum SA, Lager PJ, Carson CC, Keene JD (2002) Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26(2):191-198. doi: 10.1016/S1046-2023(02) 00022-1
27. Tenenbaum SA, Carson CC, Lager PJ, Keene JD (2000) Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci USA 97(26):14085-14090
28. Keene JD (2001) Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci USA 98(13):7018-7024. doi: 10.1073/pnas.111145598
29. Morris AR, Mukherjee N, Keene JD (2010) Systematic analysis of posttranscriptional gene expression. Wiley Interdiscip Rev Syst Biol Med 2(2):162-180. doi: 10.1002/wsbm.54
30. Orphanides G, Reinberg D (2002) A unified theory of gene expression. Cell 108(4):439-451
31. Kenan DJ, Query CC, Keene JD (1991) RNA recognition: towards identifying determinants of specificity. Trends Biochem Sci 16(6):214-220
32. Burd CG, Dreyfuss G (1994) Conserved structures and diversity of functions of RNA-binding proteins. Science 265(5172):615-621
33. Hogan DJ, Riordan DP, Gerber AP, Herschlag D, Brown PO (2008) Diverse RNA-binding proteins interact with functionally related sets of RNAs, suggesting an extensive regulatory system. PLoS Biol 6(10):e255. doi: 10.1371/journal. pbio.0060255
34. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854
35. Wightman B, Ha I, Ruvkun G (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75(5):855-862
36. Keene JD (2007) RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8(7):533-543. doi: 10.1038/nrg2111
37. Keene JD, Tenenbaum SA (2002) Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 9(6):1161-1167
38. Keene JD (2007) Biological clocks and the coordination theory of RNA operons and regulons. Cold Spring Harb Symp Quant Biol 72:157-165. doi: 10.1101/sqb.2007.72.013
39. Meltzer PS (2005) Cancer genomics: small RNAs with big impacts. Nature 435(7043):745-746. doi: 10.1038/435745a
40. Deng S, Calin GA, Croce CM, Coukos G, Zhang L (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7(17):2643-2646
41. Croce CM (2008) Oncogenes and cancer. N Engl J Med 358(5):502-511. doi: 10.1056/NEJMra072367
42. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
43. Hutvágner G, McLachlan J, Pasquinelli AE, Bálint E, Tuschl T, Zamore PD (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293(5531):834-838. doi: 10.1126/science.1062961
44. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S, Kim VN (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415-419. doi: 10.1038/nature01957
45. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522-531. doi: 10.1038/nrg1379
46. Eulalio A, Huntzinger E, Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132(1):9-14. doi: 10.1016/j.cell.2007.12.024
47. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15-20
48. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857-866. doi: 10.1038/nrc1997
49. Zhang J, Ma L (2012) MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 31(3-4):653-662. doi: 10.1007/s10555-012-9368-6
50. Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, Postigo A (2012) EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 69(20):3429-3456. doi: 10.1007/s00018-012-1122-2
51. Bullock MD, Sayan AE, Packham GK, Mirnezami AH (2012) MicroRNAs: critical regulators of epithelial-to-mesenchymal (EMT) and mesenchymal-to-epithelial transition (MET) in cancer progression. Biol Cell 104(1):3-12. doi: 10.1111/boc.201100115
52. Gregory PA, Bert A, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ (2008) The miR-200 family and miR-205 regulate epithelial-to-mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10(5):593-601
53. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22(7):894-907
54. Wellner U, Schuber J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11(12):1487-1495
55. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY, Lindeman GJ, Shannon MF, Drew PA, Khew-Goodall Y, Goodall GJ (2011) An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Cell Biol 15(22):1686-1698
56. García-Martínez J, Aranda A, Pérez-Ortín JE (2004) Genomic run-on evaluates transcription rates for all yeast genes and identifies gene regulatory mechanisms. Mol Cell 15(2):303-313. doi: 10.1016/j.molcel.2004.06.004
57. Hieronymus H, Silver PA (2004) A systems view of mRNP biology. Genes Dev 18(23):2845-2860. doi: 10.1101/gad.1256904
58. Hieronymus H, Yu MC, Silver PA (2004) Genome-wide mRNA surveillance is coupled to mRNA export. Genes Dev 18(21):2652-2662. doi: 10.1101/gad.1241204
59. Ghigna C, Valacca C, Biamonti G (2008) Alternative splicing and tumor progression. Curr Genomics 9(8):556-570. doi: 10.2174/138920208786847971
60. Biamonti G, Bonomi S, Gallo S, Ghigna C (2012) Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT). Cell Mol Life Sci 69(15):2515-2526
61. Cooper TA, Wan L, Dreyfuss G (2009) RNA and disease. Cell 136(4):777-793. doi: 10.1016/j.cell.2009.02.011
62. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP (2009) ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33(5):591-601. doi: 10.1016/j.molcel.2009.01.025
63. Warzecha CC, Shen S, Xing Y, Carstens RP (2009) The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biol 6(5):546-562
64. Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, Guo W, Xing Y, Carstens RP (2010) An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J 29(19):3286-3300. doi: 10.1038/emboj.2010.195
65. Yanagisawa M, Huveldt D, Kreinest P, Lohse CM, Cheville JC, Parker AS, Copland JA, Anastasiadis PZ (2008) A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease. J Biol Chem 283(26):18344-18354. doi: 10.1074/jbc.M801192200
66. Dittmar KA, Jiang P, Park JW, Amirikian K, Wan J, Shen S, Xing Y, Carstens RP (2012) Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing. Mol Cell Biol 32(8):1468-1482
67. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB, Gertler FB (2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7(8):e1002218
68. Wang Z, Sandiford S, Wu C, Li SS (2009) Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signalling. EMBO J 28(16):2360-2373. doi: 10.1038/emboj.2009.190
69. Dho SE, French MB, Woods SA, McGlade CJ (1999) Characterization of four mammalian numb protein isoforms. Identification of cytoplasmic and membrane-associated variants of the phosphotyrosine binding domain. J Biol Chem 274(46):33097-33104
70. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382(6592):638-642. doi: 10.1038/382638a0
71. Billin AN, Thirlwell H, Ayer DE (2000) Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol 20(18):6882-6890
72. Weise A, Bruser K, Elfert S, Wallmen B, Wittel Y, Wöhrle S, Hecht A (2010) Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets. Nucleic Acids Res 38(6):1964-1981. doi: 10.1093/nar/gkp1197
73. Ge K, DuHadaway J, Du W, Herlyn M, Rodeck U, Prendergast GC (1999) Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci USA 96(17):9689-9694
74. Goswami S, Philippar U, Sun D, Patsialou A, Avraham J, Wang W, Di Modugno F, Nistico P, Gertler FB, Condeelis JS (2009) Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin Exp Metastasis 26(2):153-159. doi: 10.1007/s10585-008-9225-8
75. Goicoechea SM, Arneman D, Otey CA (2008) The role of palladin in actin organization and cell motility. Eur J Cell Biol 87(8-9):517-525. doi: 10.1016/j.ejcb.2008.01.010
76. Goicoechea SM, Bednarski B, García-Mata R, Prentice-Dunn H, Kim HJ, Otey CA (2009) Palladin contributes to invasive motility in human breast cancer cells. Oncogene 28(4):587-598. doi: 10.1038/onc.2008.408
77. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H (2002) CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16(23):3074-3086. doi: 10.1101/gad.242602
78. Cheng C, Yaffe MB, Sharp PA (2006) A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 20(13):1715-1720. doi: 10.1101/gad.1430906
79. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, Cheng C (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 121(3):1064-1074. doi: 10.1172/JCI44540
80. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63(9):2172-2178
81. Pieters T, van Hengel J, van Roy F (2012) Functions of p120ctn in development and disease. Front Biosci 17:760-783
82. Pieters T, van Roy F, van Hengel J (2012) Functions of p120ctn isoforms in cell-cell adhesion and intracellular signaling. Front Biosci 17:1669-1694
83. Aho S, Levänsuo L, Montonen O, Kari C, Rodeck U, Uitto J (2002) Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells. J Cell Sci 115(7):1391-1402
84. Seidel B, Braeg S, Adler G, Wedlich D, Menke A (2004) E- and N-cadherin differ with respect to their associated p120ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells. Oncogene 23(32):5532-5542
85. Talvinen K, Tuikkala J, Nykänen M, Nieminen A, Anttinen J, Nevalainen OS, Hurme S, Kuopio T, Kronqvist P (2010) Altered expression of p120catenin predicts poor outcome in invasive breast cancer. J Cancer Res Clin Oncol 136(9):1377-1387. doi: 10.1007/s00432-010-0789-8
86. Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C (2005) A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 24(33):5235-5245. doi: 10.1038/sj.onc.1208741
87. Melchor L, Garcia MJ, Honrado E, Pole JC, Alvarez S, Edwards PA, Caldas C, Brenton JD, Benítez J (2007) Genomic analysis of the 8p11-12 amplicon in familial breast cancer. Int J Cancer 120(3):714-717. doi: 10.1002/ijc.22354
88. Slorach EM, Chou J, Werb Z (2011) Zepp o1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev 25(5):471-484. doi: 10.1101/gad.1998111
89. Ohkubo T, Ozawa M (2004) The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117(Pt 9):1675-1685. doi: 10.1242/jcs.01004
90. Sarrió D, Pérez-Mies B, Hardisson D, Moreno-Bueno G, Suárez A, Cano A, Martín-Pérez J, Gamallo C, Palacios J (2004) Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene 23(19):3272-3283. doi: 10.1038/sj.onc.1207439
91. Patton JG, Porro EB, Galceran J, Tempst P, Nadal-Ginard B (1993) Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev 7(3):393-406
92. Shav-Tal Y, Zipori D (2002) PSF and p54(nrb)/NonO-multi-functional nuclear proteins. FEBS Lett 531(2):109-114
93. Ghigna C, Giordano S, Shen H, Benvenuto F, Castiglioni F, Comoglio PM, Green MR, Riva S, Biamonti G (2005) Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell 20(6):881-890. doi: 10.1016/j.molcel.2005.10.026
94. Valacca C, Bonomi S, Buratti E, Pedrotti S, Baralle FE, Sette C, Ghigna C, Biamonti G (2010) Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol 191(1):87-99. doi: 10.1083/jcb.201001073
95. Lukong KE, Richard S (2003) Sam68, the KH domain-containing superSTAR. Biochim Biophys Acta 1653(2):73-86
96. Lock P, Fumagalli S, Polakis P, McCormick F, Courtneidge SA (1996) The human p62 cDNA encodes Sam68 and not the RasGAP-associated p62 protein. Cell 84(1):23-24
97. Jones AR, Schedl T (1995) Mutations in gld-1, a female germ cell-specific tumor suppressor gene in Caenorhabditis elegans, affect a conserved domain also found in Src-associated protein Sam68. Genes Dev 9(12):1491-1504
98. Isken O, Maquat LE (2008) The multiple lives of NMD factors: balancing roles in gene and genome regulation. Nat Rev Genet 9(9):699-712. doi: 10.1038/nrg2402
99. Hillman RT, Green RE, Brenner SE (2004) An unappreciated role for RNA surveillance. Genome Biol 5(2):R8. doi: 10.1186/gb-2004-5-2-r8
100. Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE (2007) Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446(7138):926-929. doi: 10.1038/nature05676
101. Saltzman AL, Kim YK, Pan Q, Fagnani MM, Maquat LE, Blencowe BJ (2008) Regulation of multiple core spliceosomal proteins by alternative splicing-coupled nonsense-mediated mRNA decay. Mol Cell Biol 28(13):4320-4330. doi: 10.1128/MCB.00361-08
102. Brennan CM, Steitz JA (2001) HuR and mRNA stability. Cell Mol Life Sci 58(2):266-277
103. Chen CY, Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20(11):465-470
104. Figueroa A, Cuadrado A, Fan J, Atasoy U, Muscat GE, Muñoz-Canoves P, Gorospe M, Muñoz A (2003) Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol 23(14):4991-5004
105. Gorospe M (2012) RNA-binding proteins: post-transcriptional control of aging traits: an introduction to a series of review articles. Ageing Res Rev 11(4):421-422. doi: 10.1016/j.arr.2012.09.001
106. Abdelmohsen K, Kuwano Y, Kim HH, Gorospe M (2008) Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 389(3):243-255. doi: 10.1515/BC.2008.022
107. Srikantan S, Gorospe M (2012) HuR function in disease. Front Biosci 17:189-205
108. Moore AE, Young LE, Dixon DA (2011) MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer Metastasis Rev 30(3-4):419-435. doi: 10.1007/s10555-011-9300-5
109. Wang W, Caldwell M, Lin S, Furneaux H, Gorospe M (2000) HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 19(10):2340-2350
110. Wang W, Yang X, Cristofalo VJ, Holbrook NJ, Gorospe M (2001) Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol 21(17):5889-5898
111. Galbán S, Martindale JL, Mazan-Mamczarz K, López de Silanes I, Fan J, Wang W, Decker J, Gorospe M (2003) Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. Mol Cell Biol 23(20):7083-7095
112. López de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES, Gorospe M (2003) Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22(46):7146-7154
113. Lal A, Kawai T, Yang X, Mazan-Mamczarz K, Gorospe M (2005) Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. EMBO J 24(10):1852-4862
114. Wang W, Fumeaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M (2000) HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20(3):760-769
115. Heinonen M, Hemmes A, Salmenkivi K, Abdelmohsen K, Vilén ST, Laakso M, Leidenius M, Salo T, Hautaniemi S, Gorospe M, Heikkilä P, Haglund C, Ristimäki A (2011) Role of RNA binding protein HuR in ductal carcinoma in situ of the breast. J Pathol 224(4):529-539
116. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436(7047):123-127. doi: 10.1038/nature03688
117. Dong R, Lu JG, Wang Q, He XL, Chu YK, Ma QJ (2007) Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. Biochem Biophys Res Commun 356(1):318-321. doi: 10.1016/j.bbrc.2007.02.145
118. Brooks SA, Connolly JE, Rigby WF (2004) The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J Immunol 172(12):7263-7271
119. Brooks SA, Blackshear PJ (2013) Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action. Biochim Biophys Acta. doi: 10.1016/j.bbagrm.2013.02.003
120. Gebeshuber CA, Zatloukal K, Martinez J (2009) miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10(4):400-405. doi: 10.1038/embor.2009.9
121. Chaudhury A, Chander P, Howe PH (2010) Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1's multifunctional regulatory roles. RNA 16(8):1449-1462. doi: 10.1261/rna.2254110
122. Wang H, Vardy L, Tan CP, Loo JM, Guo K, Li J, Lim SG, Zhou J, Chng WJ, Nq SB, Li HX, Zeng G (2010) PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Cancer Cell 18(1):52-62
123. Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T, Schreiber M, Jechlinger M, Beug H (2006) ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 10(3):227-239. doi: 10.1016/j.ccr.2006.07.020
124. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH (2010) TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 12(3):286-293. doi: 10.1038/ncb2029
125. Chaudhury A, Hussey GS, Howe PH (2011) 3′UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end. RNA Biol 8(4):595-599. doi: 10.4161/rna.8.4.16018
126. Hussey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, Wilce MC, Merrick WC, Howe PH (2011) Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell 41(4):419-431. doi: 10.1016/j.molcel.2011.02.003
127. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blöcker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, Szustakowki J, Consortium IHGS (2001) Initial sequencing and analysis of the human genome. Nature 409 (6822):860-921. doi: 10.1038/35057062
128. Hussey GS, Link LA, Brown AS, Howley BV, Chaudhury A, Howe PH (2012) Establishment of a TGFβ-induced post-transcriptional EMT gene signature. PLoS One 7(12):e52624. doi: 10.1371/journal.pone.0052624
129. Zong Q, Schummer M, Hood L, Morris DR (1999) Messenger RNA translation state: the second dimension of high-throughput expression screening. Proc Natl Acad Sci USA 96(19):10632-10636
130. Penalva LO, Tenenbaum SA, Keene JD (2004) Gene expression analysis of messenger RNP complexes. Method Mol Biol 257:125-134. doi: 10.1385/1-59259-750- 5:125
131. Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16(2):139-149. doi: 10.1016/j.cytogfr.2005.01.001
132. Savagner P, Vallés AM, Jouanneau J, Yamada KM, Thiery JP (1994) Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 5(8):851-862
133. Shirakihara T, Horiguchi K, Miyazawa K, Ehata S, Shibata T, Morita I, Miyazono K, Saitoh M (2011) TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J 30(4):783-795. doi: 10.1038/emboj.2010.351
134. Horiguchi K, Sakamoto K, Koinuma D, Semba K, Inoue A, Inoue S, Fujii H, Yamaguchi A, Miyazawa K, Miyazono K, Saitoh M (2012) TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene 31(26):3190-3201. doi: 10.1038/onc.2011.493
135. Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adélaïde J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D, Bertucci F (2006) Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25(15):2273-2284. doi: 10.1038/sj.onc.1209254
136. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6):515-527. doi: 10.1016/j.ccr.2006.10.008